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ABSTRACT 
The molecular regulation of protein-protein interactions is often accomplished via 
discrete structural changes within binding sites. The Src homology 2 (SH2) domain of 
interleukin-2 tyrosine kinase (Itk) binds two separate ligands in vitro: a phosphotyrosine-
containing peptide and the Itk SH3 domain. Binding specificity for these two ligands is 
affected by cis/trans isomerization of the Asn 286-Pro 287 imide bond in the Itk SH2 
domain. In this thesis, I describe the development of a novel method of analyzing nuclear 
magnetic resonance data, in which chemical shift perturbations and cross-peak intensities are 
correlated in order to measure the independent ligand-binding affinities of each SH2 
conformer. This method reveals the cis imide bond-containing Itk SH2 conformer to exhibit 
a 3.7-fold greater affinity for the Itk SH3 domain compared with the binding of the trans 
conformer to the same ligand. Conversely, the trans conformer binds the phosphotyrosine-
containing peptide with a 3.5-fold greater affinity than the cis conformer. In addition to 
furthering the understanding of this system, the method presented here is of general 
application in quantitatively determining the specificities of conformationally heterogeneous 
systems that use a molecular switch to regulate binding to multiple distinct ligands. 
CHAPTER 1: INTRODUCTION AND BACKGROUND 
Background and Significance 
Kinases, modular domains, and their roles in cellular signaling 
Organisms rely on cellular signaling in order to regulate processes in many types of 
tissues. Great progress has been made in the last two decades to understand the molecular 
basis by which cells are capable of transmitting messages, and the mechanisms by which the 
accuracy of these communications is ensured. The paradigm that has emerged is that 
modular domains - relatively small sequences of around 100 amino acids that adopt specific 
three-dimensional structures within proteins - play a large role in governing the precision of 
cellular signaling pathways. These domains influence cellular signaling not through direct 
catalysis, but rather through protein-protein interactions. Understanding the structural 
mechanisms by which protein-protein interactions occur and are controlled has thus become 
a central goal not only in the understanding of cellular communication, but of biochemistry 
in general. 
1 
The first protein in which these domains were observed and their importance realized 
was the tyrosine kinase Src. Kinases are an extremely important group of enzymes 
responsible for the transfer of phosphoryl groups, usually from ATP to a specific molecular 
target. This transfer is a fundamental molecular switch and plays a central role in the 
regulation of numerous cellular pathways. Eukaryotic kinases share a fair amount of 
sequence homology, and are composed of two subgroups: those that phosphorylate serine or 
threonine, and those that phosphorylate tyrosine. Due to their vital cellular roles, including 
the regulation of mitosis, many oncogenes code for tyrosine kinases with defective regulatory 
mechanisms1, thereby underscoring the importance of proper control of these kinases. 
The study of Src revealed that, in addition to the kinase domain, the protein contains 
two noncatalytic elements with sequence homology to elements found in other proteins2·3 . 
These elements, termed SH2 and SH3 (Src Homology 2 and 3) domains were discovered to 
have a folded structure2 and function4 independent of the kinase domain, yet were essential 
for the proper localization of Src and strongly affected kinase activity. These domains have 
since been discovered in hundreds of proteins, and many other types of domains have been 
discovered since these initial landmark discoveries, including PH, PTB, PDZ, and WW 
domains5, Protein modules have now been observed to play fairly universally conserved 
roles in a wide variety of cellular processes. 
The discovery and characterization of these protein modules has revolutionized our 
understanding of the organization and evolution of cell signaling pathways. With the 
emerging model of the living cell as a highly structured and organized entity, the importance 
of enzyme targeting and localization within the cell is being increasingly realized, as is the 
role of protein-protein interaction domains in organizing the assembly of these protein 
networks6 • 
2 
The past decade has also seen the determination of the crystal structures of a wide 
variety of protein kinases7• These structures have suggested that the catalytic domains of 
eukaryotic kinases, in addition to their sequence homology, are also structurally conserved. 
However, these same crystallographic analyses revealed that despite the similarity of kinase 
domain structure, there exists a wide variety of means employed by the cell to control the 
activation and deactivation of these kinases. Understanding the mechanisms that underlie the 
regulation of kinases has therefore proven to be an important area of continuing research. 
Further structural studies of Src and the family of proteins to which it belongs (the 
Src-farnily) revealed a particularly fascinating system of control, in which its SH2 and SH3 
domains play a direct role in allosteric regulation of the kinase domain8 • To date, Src-family 
kinases are the only nonreceptor tyrosine kinases for which the mechanism of activation and 
deactivation of catalytic activity is well understood. The Src-family has thus become a 
model for the manner in which protein domain-mediated tyrosine kinase regulation is 
achieved. 
Insights into nonreceptor tyrosine kinase regulation from the Src-family 
3 
The Src family is the largest family of nonreceptor tyrosine kinases. All Src family 
members share a common domain organization that provides the foundation for what seems 
to be a conserved regulatory mechanism (Figure 1-1 ). Each protein contains an N-terminal 
region responsible for membrane localization (called an SH4 domain), followed by a variable 
region of 40-70 residues. Continuing in the C-direction, Src kinases then contain an SH3 
domain, an SH2 domain, a kinase domain, and a C-terminal tail8• 
-
Variable 
SH4 SH3 SH2 - Kinase domain 
-
Figure 1-1. Domain structure of the Src family kinases. Only the SH3 through C-terminus 
fragment is required for the inhibition of the kinase domain, which is catalytically active 
when expressed alone. 
The mechanism of Src regulation emerged following the determination of several key 
structures of Src-family protein fragments, all within a short window of time. First, a Src-
family kinase domain (Lek) was crystallized in the active form9 • Soon after, the structures of 
two family member fragments including their regulatory domains (Src and Hck), were 
determined in the down-regulated form 10•11 • Together, this set of structures has suggested a 
general model for the regulation of Src-family kinases. 
4 
The structure of the catalytic domain of Lek in the active state is very similar to other 
structures of active kinase domains, most notably that of protein kinase A12 . Like other 
kinase domains, Src-family kinase domains consist of two lobes: a smaller N-terminal lobe, 
and a larger C-terminal lobe. The ATP-binding site and catalytic cleft are located in the 
interface between the lobes. 
Unexpectedly, however, the crystallization of the larger fragments of Src and Hck 
revealed a novel contribution to the kinase structure provided by the SH3 and SH2 domains, 
as well as the C-terminal tail. The SH2 domain was observed bound to a phosphotyrosine 
residue in the tail, and the SH3 domain was seen bound to a polyproline helix in the linker 
between the SH2 domain and the kinase. The effect of these interactions, which occur on the 
opposite side of the kinase domain from the catalytic cleft, is to pull on each lobe, displacing 
key structural features of the catalytic cleft. These interesting structural findings reveal that, 
in addition to their role in targeting, SH2 and SH3 domains are capable of regulating the 
kinase domains to which they are attached, a finding which may tum out to be a common 
feature of tyrosine kinase control. 
The cellular role(s) of Itk 
The significant advances that have been made in understanding signaling pathways in 
the past two decades have also shed considerable light on the process of the engagement of 
immune response. Tyrosine kinases, particularly those of the Tee family, have been 
demonstrated to play critical roles in this process. Among them, the Tee kinase Itk 
(Emt/Tsk) plays a large role in modulating T cell signaling pathwaysIJ. 
The experiments that have been conducted thus far have suggested the following 
general model for ltk' s role in T cell signal transduction following engagement of the antigen 
receptor. The phosphorylation of LAT (linker for activation of T cells) by Zap70 leads to the 
recruitment of multiple signaling molecules, including ltk14·15 • Once there, it is 
phosphorylated by Lek on Tyr 5·11 in the activation loop of the kinase domain, which leads 
to the activation of Itk16• Itk activation in tum leads to the phosphorylation and activation of 
PLC-yl, a crucial event in calcium mobilization that in tum leads to T cell activation 17 • 
While there is ample experimental evidence describing the biology of Itk during T 
cell activation, much less is known about the structural differences between active and 
inactive Itk. The crystal structures of the Itk kinase domain in phosphorylated and 
dephosphorylated states reveal that only minor structural differences occur in the kinase 
domain upon phosphorylation of Tyr 511, and that additional effects contributed by the 
regulatory domains appear to be necessary in order to explain the kinase activation 18 • 
5 
This, of course, would be similar to the case in the Src family, where the SH2 and 
SH3 domains are necessary to modify the structure of the kinase domain. Like the Src 
kinases, Itk contains a kinase domain preceded by SH2 and SH3 domains. However, unlike 
Src kinases, Itk and the other Tee kinases do not contain the C-terminal tail so crucial to Src 
regulation, which indicates that the activation of the kinase domain must occur via a different 
mechanism, also seemingly involving the regulatory domains. 
The domain structure of Itk, in addition to the features mentioned above, includes an 
N-terminal pleckstrin homology (PH) domain that is responsible for the recruitment of Itk to 
the cell membrane, and a Tee homology (TH) domain, which includes a praline-rich region 
immediately upstream of the SH3 domain. The domain structure of Itk is presented in Figure 
1-2, which als<? discusses some of the protein-protein interactions that each domain has been 
implicated in. As can be seen by the number of different interactions they take part in, the 
regulatory domains may have multiple roles depending on the environment and regulatory 
state of Itk. 
The structures of the Itk kinase domain are the only crystal structures available for the 
protein. In the absence of data from X-ray crystallography regarding the structures of active 
and inactive ltk, information regarding the mechanism of kinase regulation have come from . 
6 
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Figure 1-2. Domain structure of Itk. The domains and their known roles are as follows 19• 
PH (pleckstrin homology) domains interact with phospholipids as well as a variety of 
proteins usually found near the cell surface. The Itk PH domain is believed responsible for 
recruitment of Itk to the cell membrane signaling complexes. The function of TH (Tee 
homology) domains are not yet clear, although the PR (proline-rich) region is an SH3 ligand 
and forms an intramolecular complex with the neighboring SH3 domain. SH3 domains bind 
proline-rich regions, and in Itk, also interact in an intermolecular fashion with the Itk SH2 
domain. The SH2 domain, in addition its SH3 interaction, also binds phosphorylated 
tyrosine residues in certain proteins. All Tee kinases possess SH3, SH2, and kinase domains, 
although the domain organization at the N-terminus is somewhat variable between its 
members. The above organization, however, is shared by Itk, Tee, and Btk. 
NMR spectroscopy. In recent years, the structures of the Itk SH2 domain and the Itk PR-
SH3 fragment have been solved using NMR20•21 • The structure of the PR-SH3 fragment 
revealed an intramolecular interaction between the proline rich region and the SH3 domain, 
while another NMR study has demonstrated that the SH3-SH2 fragment of Itk dimerizes22 . 
While the functional significance of these structural findings is unclear, these inter- and 
intramolecular regulatory domain interactions provide tantalizing clues suggesting the 
possible mechanisms that may be at play in Itk activation and deactivation. 
7 
The SH2 and SH3 domains of Itk may function to provide a mechanism for the direct 
regulation of the kinase, as they do in Src. Alternatively, their principal function may be to 
affect cellular localization. Their role could also involve other possibilities, such as the 
binding of an inhibitor or effector, or indeed some combination of the above roles. 
Regardless, however, of the role they play, these domains are certainly important for Itk 
cellular function and the means by which these roles are structurally modulated is an 
interesting question that is currently best answered using NMR spectroscopy. 
Approach 
NMR is a powerful tool to probe regulatory domain interactions 
Nuclear magnetic resonance (NMR), apart from its utility as a structure-determination 
method, has a wide range of applications to the study of protein-protein interactions. NMR 
techniques have been developed to map binding surfaces, reveal intermolecular contacts 
between atoms, investigate allosteric effects, study induced changes in protein dynamics, and 
measure the affinity, specificity, and kinetics of binding23•25 • Due to the wealth of 
information obtained by NMR, there is a large and growing body of data collection and 
analysis methods available with which to study molecular interactions. 
The tractable nature of regulatory domains makes them ideal candidates for study by 
NMR. Regulatory domains can be easily and relatively inexpensively labeled with 15N by 
growing an E. coli production strain in minimal media using 15NH4Cl as the sole nitrogen 
source. Once grown, these proteins can be harvested, purified, and studied in a variety of 
waysbyNMR. 
HSQC spectroscopy 
8 
The most common NMR experiment carried out with 15N-labeled protein is the 1H-
15N heteronuclear single-quantum correlation experiment, or HSQC. This experiment yields 
a two-dimensional spectrum correlating the chemical shifts of protons with the chemical 
shifts of attached, isotopically-labeled, nitrogens. In an 15N-labeled protein, then, signals are 
seen for all protons that are covalently attached to nitrogen. The spectrum contains peaks for 
the side-chains of tryptophan, lysine, and arginine, but the most common signal is given by 
backbone amide groups. Excepting proline (which has no amide protons), the backbone of 
every amino acid therefore produces a single peak and serves as an excellent reporter for the 
chemical environment of the residue. An HSQC spectrum is shown in Figure 2-1. A 
detailed description (including pulse diagrams) of the HSQC experiment can be found in Ref. 
24. 
Because the HSQC spectrum contains roughly one signal for each amino acid, the 
experiment is often said to provide a "fingerprint" of the protein. The most common usage 
of this fingerprint for the study of protein-protein interactions is the mapping of chemical 
shift perturbations. In perturbation mapping, the HSQC of one protein is monitored while an 
unlabeled binding partner is added. An interaction between the proteins causes changes in 
the local chemical environment of each residue on the binding surface. Due to the high 
sensitivity of chemical shifts, these changes are easily observed in the spectra. Residues for 
which the magnitude of chemical shift is significant can then be mapped onto the surface 
representation of a protein in order to delineate a contiguous binding surface. 
NMR titrations 
9 
The study of chemical shift perturbation can be done in a quantitative manner as well. 
The analysis of NMR titrations varies depending on the exchange regime of the interaction 
event. Exchange regimes, and issues that arise in the quantitation of NMR data, are 
discussed below. 
Exchange regimes 
Chemical exchange between NMR peaks of different frequencies can manifest itself 
in one of three ways, depending on the exchange rate of the event relative to the NMR 
timescale: slow exchange, in which a peak at both frequencies can be observed and 
monitored independently;fast exchange, in which a single peak is observed, whose position 
corresponds to the weighted average of the two individual chemical shifts; and intermediate 
exchange, in which the signals become poorly defined, extensive broadening occurs, and the 
peaks may become indistinguishable from noise. Unlike fast and slow exchange, the poorly 
resolved data given by intermediate exchange generally precludes quantitative analysis in an 
NMR titration. 
Concentration measurements of the protein substates giving rise to the spectral 
signals differ depending on the exchange regime. Fast exchange events give rise to signals 
that vary continuously between the chemical shifts of the free and bound protein states, 
depending on the concentration of each state. This type of exchange is quantified, then, by 
following the chemical shift of the center of a resonance over the course of a titration. Fast 
exchange is typically observed for fairly weak protein-protein interactions. Figure 1-3 
demonstrates the way in which fast exchange appears in an NMR spectrum. 
Stronger binding events, along with slow/irreversible modifications, such as 
phosphorylation, give rise to slow exchange. In order to quantify slow exchange, one 
measures the intensities of the signals given off by each of the two states, thereby obtaining 
their population ratio. While this sounds trivial, in practice there are many concerns 
associated with obtaining reliable quantitative data from these measurements. 
Measurement of NMR signal intensity 
10 
The intensity of an NMR peak is most accurately measured by integrating the three-
dimensional volume of the NMR peak, as opposed to simply observing the height of the peak 
at maximum amplitude. There are two reasons for this: (1) spectral noise will average to 
zero over the area of integration, and (2) the volume of an NMR peak is independent of 
broadening, which can occur in an NMR spectrum for a number of reasons, including T2 
relaxation and ligand binding. 
In protein NMR spectroscopy, the intensity of a signal is affected by a number of 
factors (e.g. coupling constants, NMR field strength, buffer conditions). When comparing 
the signal intensity given off by the same residue in separate states of the same protein in the 
same NMR tube, however, almost all of these factors are equivalent between the two states. 
The signal intensity in this case is linearly proportional to the number of protons in the 
sample giving rise to the signal (i.e. the population of the state). One possible source of 
discrepancy, however, is a difference between the two states in the 1H T 1 relaxation rate for a 
given amide group to be measured in the titration. This rate depends on the internal motions 
and local flexibility of the protein, and governs the rate at which magnetization of that proton 
is returned to its equilibrium magnitude. If a proton in one of the two states does not recover 
the same amount of magnetization between pulses as a proton in the other, the two protons 
will not give the same intensity of signal, and thereby skew the measurement of the 
11 
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FIGURE 1-3. Select region of the HSQC spectrum for 15N-labeled Itk SH2 upon addition of 
a phosphopeptide ligand (black - 0.32 mM ltk SH2; green - 0.31 SH2 + 0.06 mM p Y; red -
0.31SH2+0.17 mM pY; blue -0.29 SH2 + 2.58 mM pY). The black peak is the position of 
the HSQC peak for Phe 312 in the absence of ligand. The blue peak represents SH2 after the 
addition of 9-fold excess of phosphopeptide, which is sufficient to bind >99% of the SH2 in 
solution, and therefore depicts Phe 312 in the p Y -bound state. This figure is an illustration of 
an exchange process that is faster than the NMR timescale. For a depiction of slow 
exchange, see Figure 2-4. 
population ratio of the two states. These effects, while ignored in most studies, can 
nevertheless be significant in certain protein regions. 
12 
In addition to requiring relaxation uniformity between substates, the residues used for 
a quantitative analysis of slow exchange must also be chosen for their isolation from other 
peaks so as to guarantee the ability to include adequate integration boundaries without errors 
due to peak overlap. However, if these two criteria are met, integrating peak volumes will 
correctly correspond to the cis/trans ratio provided that the peaks are accurately integrated. 
Thesis Organization 
In this chapter, I have given a general introduction to the background of signal 
transduction kinases and some details of NMR spectroscopy that have proved relevant in 
conducting the research outlined in the rest of this thesis. Chapter 2 describes the 
development of a method for analyzing NMR data in order to quantify the independent 
ligand-binding affinities of each conformer in a conformationally heterogenous protein, the 
Itk SH2 domain. Chapter 3 describes the future directions of this work, presents preliminary 
data to highlight those directions, and discusses the significance of this research. 
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CHAPTER 2: MODULATION OF LIGAND SPECIFICITY BY PROLYL 
CIS/TRANS ISOMERIZATION IN THE ITK SH2 DOl\ilAIN 
Introduction 
Previous in vitro investigations studying the SH2 domain of Itk have revealed two 
intriguing facets of its structure and function: (a) Itk SH2 adopts two stable conformations 
that are capable of slowly interconverting, and (b) Itk SH2 is capable of independently 
binding two distinct ligands. The relationship between these two findings and the 
development of a method to probe that relationship is the central theme of this chapter. 
ltk SH2 conformational heterogeneity 
Cellular control over a protein's function is often achieved through structural 
rearrangement, which can be triggered by a variety of mechanisms. Most of the currently 
known mechanisms involve covalent modification, due to the fact that these modifications 
are easily and inexpensively detected. Recently, however, it is becoming clear that the 
structures of a number of proteins are modified in a noncovalent manner1.2 • The observation 
of these noncovalent structural modifications is unlikely using most biochemical techniques. 
NMR, however, is unique in its ability to observe dynamic structural processes, and is thus 
an incredibly useful technique in the study of such events. 
Early NMR spectra of the Itk SH2 domain revealed that the domain adopts two 
distinct low-energy conformations in solution (Figure 2-1 ). Varying the temperature at 
which these spectra were recorded demonstrated that the two conformers freely 
interconverted in solution, although the slow rate of the conformational exchange suggested 
the existence of a significant energy barrier between the conformers. This led to the idea that 
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Figure 2-1. 1H- 15N HSQC spectrum of 15N-labeled Itk SH2. This spectra reveals 
substantially more backbone amide signals than there are backbone amide groups in the 
construct. Subsequent NMR resonance assignments showed that this observation was due to 
conformationally distinct resonance frequencies that occur in 35 of the 109 SH2 residues. 
Additional NMR experiments demonstrated that the two conformations correlated with the 
configuration of the Asn 286-Pro 287 imide bond. Regions of high peak density have been 
expanded for clarity. Figure adapted from R. Mallis et. al. 3 
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the barrier was provided by the cis/trans isomerization of a backbone peptidyl-prolyl imide 
bond. While this isomerization event is fairly common in short peptides, examples for which 
proline isomerization has been detected in folded proteins is rare, although this is perhaps 
due to the difficulty of observing isomerization using techniques other than NMR. 
Nevertheless, characteristic NOE correlations4 between Asn-286 and Pro-287 verified that 
the orientation of the imide bond between these residues correlates to each of the two 
conformations (hereafter, the cis and trans imide bond-containing conformations are referred 
to as the cis and trans conformations of Itk SH2). 
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0 
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Pro 287 
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cis prolyl 
imide bond 
Pro 287 
Figure 2-2. Chemical illustration of the prolyl imide bond isomerization event that occurs in 
Itk SH2. 
Among the naturally occurring amino acids, praline is the only residue for which both 
bond orientations are thermodynamically feasible. A mutation of Pro-287 to glycine, whose 
bond to the previous residue exclusively adopts the trans orientation, was therefore predicted 
to populate only the trans conformation. This prediction was then confirmed5, demonstrating 
that the conformational heterogeneity of Irk SH2 is dependent on the thermodynamic stability 
of both orientations of the 286-287 imide bond. 
These observations are further supported by the structure determination of both cis 
and trans conformations by NMR3, which reveals the significant structural changes in the 
SH2 domain that occur dependent on the conformation of the imide bond. Surface 
representations of the ltk SH2 domain illustrating the two conformations and the regions 
affected by ligand binding are presented in Figure 2-3. 
Itk SH2 ligand binding 
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The Itk SH2 domain is capable of independently binding in vitro to two distinct 
ligands: phosphotyrosine-containing peptides and the ltk SH3 domain6• Phosphopeptide 
binding is common to all SH2 domains, whereas the interaction with an SH3 domain seems, 
so far, to be unique to Itk. 
The structural changes in Itk SH2 that occur as a result of praline isomerization 
impart different ligand-binding affinities to each conformer. This conformer-specific nature 
of ltk SH2 ligand recognition is evident in NMR spectra of the protein/ligand complexes. 
Addition of phosphopeptide to the SH2 domain shifts the equilibrium to favor the trans 
conformer, resulting in changes in the volumes of the NMR peaks corresponding to each 
conformer (Figure 2-4 a and b). Also, ligand-induced chemical shift changes are larger for 
peaks corresponding to residues in the trans conformation than for those corresponding to 
residues in the cis conformation. In contrast, binding of the ltk SH3 domain to the SH2 
domain shifts the cis/trans equilibrium to favor the cis conformer (Figure 2-4 c). In this case, 
shifts in the positions of HSQC peaks corresponding to the cis conformation, and not that of 
the trans, are observed in the HSQC spectrum to which recombinant ltk SH3 domain has 
been added5• This seems to be the first demonstration of ligand recognition that is governed 
by the conformation of a single prolyl imide bond within a folded protein. 
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a P287 cis 
b P287 trans 
Figure 2-3. Surface representations of the Itk SH2 domain in the (a) cis and (b) trans 
conformations. On each model, the position of Pro 287 is indicated, and the conformation-
doubled residues are demarcated with a dotted line. Chemical shift perturbations that occur 
on addition of equimolar Itk SH3 domain are mapped onto the cis model and highlighted in 
gray (a). Similarly, SH2 residues that undergo chemical shift perturbations upon addition of 
3-fold excess of phosphopeptide are highlighted in yellow on the trans model (b ). For both 
models, residues that remain unperturbed upon addition of ligand are colored red. Figure 
rendered with MOLMOL7. Adapted from Brazin et. al. 5 
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Figure 2-4. (a) Select region of the HSQC spectrum of 15N-labeled Itk SH2 showing the 
conformation-doubled resonances of Lys 258. The peaks corresponding to the cis and trans 
imide bond-containing conformations are labeled. (b) Corresponding region for 15N-labeled 
Itk SH2 domain following addition of a 9-fold excess of phosphopeptide. (c) Corresponding 
region for !SN-labeled Itk SH2 domain following addition of a 7-fold excess ofltk SH3 
domain. 
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The proline-dependent conformational switch of Itk SH2 represents a novel form of 
control over protein-protein interactions. It is difficult at this point to say how widespread 
the existence of proline switches may be1• However, this type of reversible, noncovalent 
structural modification could provide an organism with significant advantages in the creation 
of dynamic signaling networks of the type that Itk appears to be involved in. 
The full analysis of these networks requires a quantitative understanding of the affinity of 
protein-ligand interactions and the extent to which those affinities are regulated by 
conformational changes. This information cannot be obtained from the qualitative analysis 
that has been accomplished thus far. The development of methods to analyze the effect of 
conformational exchange on ligand binding in a quantitative manner could therefore prove a 
valuable tool in understanding molecular switches. 
Experimental Methods 
Data collection 
Protein expression and purification 
cDNA for full length Itk was supplied by the laboratory of Dr. Leslie Berg. 
Constructs coding for the SH2 and SH2 domains were amplified by PCR and ligated into 
pGEX-2T plasrpids, where they would be expressed as glutathione-S-transferase (GST) 
fusion proteins. DNA sequencing performed by the Iowa State University DNA Sequencing 
and Synthesis Facility verified the accuracy of all constructed plasmids used in this research. 
Protein domains were expressed as OST-fusions in the E. coli strain BL21 (DE3). LB 
media was used to grow unlabeled proteins, whereas modified M9 minimal media containing 
isN-enriched ammonium chloride was used to generate isN-labeled proteins. When the E. 
coli growth had reached mid-log phase, as verified by optical density measurements at 600 
nm, the temperature was reduced from 37°C to 15°C and protein expression induced by 
addition of 1 mM isopropyl ~-D-thiogalactopyranoside (IPTG). Expression was then 
allowed to proceed for 24 hours. Cells were then collected by centrifugation and 
resuspended in potassium phosphate buffer (50 mM potassium phosphate, 75 mM sodium 
chloride, 2 mM dithiothreitol, dissolved in electrolyte-pure water plus 0.002% sodium azide, 
adjusted to pH 7.4 using 3M sodium hydroxide). Lysozyme was then added and the cells 
stored at -80°C for at least 12 hours. 
Cells were lysed upon thawing to room temperature. Protease inhibitor (PMSF) and 
DNase were added, and the cell lysate separated by centrifugation. The resulting supernatant 
was purified using a glutathione-agarose column. After extensive washing, the fusion protein 
was then eluted using 10 mM glutathione in potassium phosphate buff er. Proteins were 
concentrated and loaded onto a gel filtration column (Sephacryl S-100 HR). The protein-
containing fractions were then pooled and cleaved at room temperature with thrombin for 3 
hours (ltk SH2) or 12-16 hours (Itk SH3). Following cleavage, the proteins were passed over 
the glutathione column to remove GST, and once again concentrated and loaded onto the gel 
filtration column. 
Protein-containing fractions were then checked for purity by SDS-PAGE and 
concentrated to final NMR levels. The concentration of the protein stocks was obtained by 
measuring UV absorption at 280 nm. All samples were stored at 5°C. 
Peptide synthesis and purification 
The phosphotyrosine-containing peptide ADp YEPPPSNDE was synthesized by the 
Iowa State University Protein Facility using standard solid-phase peptide synthetic 
techniques. The peptide was then purified using reversed-phase high performance liquid 
chromatography (HPLC) and lyophilized. The peptide was then resuspended in electrolyte-
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pure water and its concentration measured using amino acid analysis, also carried out by the 
Iowa State University Protein Facility. 
NMR spectroscopy 
NMR spectra were acquired using a Bruker DRXSOO spectrometer operating at a 1 H 
frequency of 499.867 MHz. A 5 mm triple resonance ('H/ 13C/15N) probe with XYZ field 
gradients was used for all experiments. All NMR spectra recorded at 25°C. Gradient-
enhanced HSQC experiments8 were used for all spectra. Sequential assignments of both SH2 
and SH3 domains were previously completed6•9• Data were acquired and processed using 
XWinNMR (Version 2.1, Bruker Instruments). 
Data analysis 
The NMRView 10 software package was used to view the NMR spectra in order to 
observe chemical shift changes and peak volumes. Peak volumes were measured using the 
elliptical volumes algorithm of NMRView. Determination of peak centers as well as volume 
integration boundaries were performed manually. Matlab (version 5.3.1, The Mathworks 
Inc.) was used for all equation fitting. Matlab scripts detailing the equation fitting procedures 
and algorithms used are available in Appendix B. 
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Results and Discussion 
Measurement of equilibrium constants using NMR 
The simplest model for SH2 binding to a ligand is given by: 
K 
-P+L PL (1) 
where Pis the protein (Itk SH2), L the ligand (either phosphopeptide or Itk SH3), PL the 
protein/ligand complex, and K the association constant. The existence of well-resolved 
HSQC peaks that are affected by ligand binding allows for the measurement of chemical shift 
changes in the NMR tube upon addition of ligand. The normalized chemical shift of a peak, 
I Dobs-Dfree I I I Doound-Dfree I , or !:!.of !:J.Dmax• is a direct measurement of fb, the fraction of SH2 in the 
ligand-bound state. This can then be used to extract the association constant K using the 
following equation11 : 
(2) 
where P 0 and L0 represent the total concentrations of protein (Itk SH2) and ligand (Itk SH3 or 
phosphopeptide). Kand !:J.omax are the only unknown parameters in the above equation, and 
both are optimized in the fitting of data to (2). 
In addition to the requirements for reporter peaks to be well-resolved and to display 
measurable chemical shift differences between free and bound states, it is also necessary for 
the peak to be unaffected by cis/trans isomerization. The reason for this is that the cis and 
trans conformers of the peptide undergo interconversion, and are allowed, therefore, to vary 
in concentration during the course of a titration. 
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Based on these requirements, five SH2 HSQC peaks (N241, Y292, V311, F312, and 
L318) were used to determine the binding affinity of phosphopeptide to Itk SH2 (Figure 2-5 
a). In the case of Itk SH3 binding, no Itk SH2 peaks were found that fit all the necessary 
requirements. The observed association constant between SH2 and SH3 was therefore 
measured using the reverse labeling scheme (unlabeled SH2 domain titrated into 15N-labeled 
SH3 domain). The concentration dependence of the normalized chemical shifts for five SH3 
HSQC peaks (Y180, W208, W209, A221, and S223) are shown in Figure 2-5 b. The 
association constant for each binding event is reported in Table 2. 
Throughout a titration, the total concentrations of protein and ligand are known; 
therefore, once the association constant has been determined,fb can be calculated at each 
point using (2). Meanwhile, the integrated volumes of the cis and trans peaks for 
conformational exchange-doubled residues give a direct measurement of .fc, the fraction of the 
SH2 domain in the cis conformation. The relationship between.fc andfi, is linear (derivation 
in later section). Therefore, if the Itk SH3 domain binds exclusively to the cis Itk SH2 
conformer, then at Ji, = 1, t. will also equal 1. Similarly, for the phosphopeptide titration, at Ji, 
= 1 a value of Jc= 0 is be expected if only the trans conformer is able to bind the peptide. 
This, however, is not the case for either the phosphopeptide or the SH3 titrations (Figure 2-6, 
a and b, respectively). This observation indicates that both SH2 conformers have measurable 
affinities for each of the SH2 ligands, and shows that a new SH2 ligand-binding model must 
be developed which takes this into account. 
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Figure 2-5. Concentration dependence of normalized chemical shifts for (a) titration of 
phosphopeptide into isN-labeled Itk SH2 domain (0.32 mM) and (b) titration of unlabeled Itk 
SH2 domain into isN-labeled Itk SH3 domain (0.32 mM). In both cases, the curves depict 
the best fit of (2) to the NMR data. Error bars represent two standard deviations about the 
mean. 
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The cis/trans ligand-binding model 
Based on these findings, the following equilibrium model was proposed for each SH2 
ligand: 
pt+ L 
J(, 
P'L 
K'1( J(K'L 
pc +L 
Kc 
pcL 
where the c and t subscripts refer to the cis and trans imide-bond containing conformers, 
respectively. It is not necessary, however, to include all four of the above equilibrium 
constants in a mathematical description of the system. One of the constants may be rewritten 
in terms of the other three (see Derivations of the governing equations). While to some 
extent, the question of which equilibrium constants to work with is arbitrary, I have decided 
to mathematically model the system using K', Kc, and Kl' leaving out K'L· This decision was 
made for the following three reasons: (a) It is unknown whether the cis/trans isomerization of 
ligand-bound SH2 occurs directly in solution, (b) the focus of this work is the effect of 
isomerization upon binding affinity, rather than the effect of ligand binding upon 
isomerization, and (c) unlike K', K'L cannot be directly measured experimentally. Regardless 
of how the model is written, the results will be the same. The calculated values of K' L for 
each ligand are reported in the caption of Table 2-2. 
It should be noted that the model presented above would be affected .by the 
oligomerizaion of any of the species involved. The assumption that this does not occur is 
well justified due to the fact that NMR studies of Itk SH2 (K. Brazin & A. Andreotti, 
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unpublished results), Itk SH3 12, and phosphopeptide (M. Sundd & A. Andreotti, unpublished 
results) reveal no indication of oligomerization. For Itk SH2 in particular, a concentration 
dependence study was run on over the range 0.01 mM to lmM, and no changes in the HSQC 
spectrum were observed. These experiments also establish that the cis/trans ratio of the Itk 
SH2 domain is not subject to concentration dependent effects. 
Overview of the fitting process 
The application of conventional binding assays to the study of SH2 behavior would 
only reveal an averaging of the behavior of the two conformations, thereby masking the 
ability to measure each conformer separately. The above model highlights the fact that the 
simple association constant represented in (1) and (2) is an inaccurate representation of the 
association of SH2 and ligand. For this reason, the association constant given by (2) is 
renamed from this point on K0 • The subscript refers to the fact that this is an "observed" 
association constant which does not take into account the two conformations of the SH2 
domain, but rather blends the affinities of each conformer into an overall, observed, 
association constant. 
By revealing the inadequacy of the observed association constant to describe the 
chemical equilibria, the cis/trans ligand-binding model also makes clear the need to measure 
independent ligand-binding affinities, Kc and Kn for each conformer. Accomplishing this 
requires deriving equations from the model presented above which can be fit to accurately 
measurable NMR data in a manner that is both computationally feasible and yields consistent 
results, regardless of the residue used to quantify the equilibrium constant. In fitting 
equations to data, the reliability of the fit is greatly improved by limiting to as low a number 
as possible the number of unknown parameters that must be fit to the data. The method 
developed here takes the following approach for each ligand. First, K0 is fit to chemical shift 
data using the well-established method described by Equation 2. Second, conformer-ligand 
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affinities are fit to peak volume integration data using a single fit with a single unknown 
parameter. Both fits are accomplished using unconstrained nonlinear optimization 
algorithms. 
As described earlier, the relationship betweenfb and..fc is linear. This linear 
relationship depends on the relative ligand-binding affinities of the cis and trans 
conformations, Kc and Kt: 
K'(K -K) K' 
le = (1 + K')(;1 + ~cK') lb + (1 + K') (3) 
To increase the accuracy of the fit, K0 can be used to determine the relationship between Kc 
(4) 
so that (3) may be rewritten as a function involving only one unknown parameter and fit to 
the NMR volume integration data (choice of Kt or K is arbitrary - after the fit, ( 4) is used to 
determine the other association constant in a manner independent of which parameter is 
. actually used in the fit and which one is calculated afterwards). The derivations of (3) and 
( 4) are presented below. 
Derivation of the governing equations 
The cis/trans model as presented here is defined by these five equations: 
(5) 
[P"L] 
K =---
c [Pc][L] 
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(6) 
(7) 
(8) 
(9) 
In the derivations that follow, the identities below, easily derived from Equations 5-7, prove 
useful: 
(10) 
(11) 
It is worth noting that ( 11) is equivalent to writing the model in a way that includes 
the K'L term. It is apparent that K'L may be rewritten as KcK'/Kr without a loss of generality. 
Derivation of (3) 
The quantities/b and..fc are defined in this system as: 
f' =[Pc]+ [P"L] 
Jc P, 
0 
(12) 
f', = [PcL]+[PrL] 
Jo p 
0 
(13) 
Equation 3 consists of transforming Equation 12 into an equation linear inf,. 
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To begin, both the numerator and denominator of Equation 12 can be multiplied by ( 1 
K1 [P'] + K1K'[P'] + KcK'[P'] + KcK'2 [P'] + K1 [P'L] + K1K'[P'L] + KcK'[P'L] + KcK'2 [P'L] 
fc = Po(l + K')(K1 + KcK') 
We can then factor the terms in the numerator into three groups by using (10) and (11): 
K,K'[P'] + K,K'[P'] + KcK'2 [pt]+ KcK'2 [?'] + KcK'[P1L] + KcK'2 [P1L] + KcK'[P' L] + KcK'2 [P'L] 
fc = I'o(l + K')(K1 + KcK') 
where in Equation 14, the four variables that were associated with the constant KcKf2 are 
rewritten as P0 by using (8). We can then use (8) to rewrite the K1K'terrn and refactor 
variables: 
KcK'([PcL] +[Pt L]) + KtK'(P0 -[PcL]-[Pt L]) + KcK' 2 P0 
fc = P0 (1 + K')(Kt + KcK') 
f, = K'(Kc - Kt )([PCL] +[Pt L]) + K'(Kt + KcK')Po 
c P0 (1+K')(Kt +KcK') 
K'(Kc - Kt )([Pc L] + [P' L]) K'(Kt + KcK')Po 
le = PoO + K')(Kt + KcK') + PoO + K')(Kt + KcK') 
K'(K -K) K' 
fc = (1 + K')(~, + ~cK') fb + (1 + K') (15) 
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Derivation of (4) 
In the system given by (5)-(9), K0 must be rewritten in order to account for cis/trans 
isomerization: 
K = [pr L] + [pc L] 
0 ([P1 ]+[Pc])[L] 
(16) 
The right side of (16) can be rewritten using (10) and (11) to yield: 
(17) 
Then, using (5), the right side of (17) becomes 
K = K, +KcK' 
0 l+K' 
(18) 
Application of the cis/trans ligand-binding model to ltk SH2 
If quantitative claims are to be made regarding the relative concentration of cis and 
trans conformers in solution on the basis of residue signal intensity, the effect of differential 
relaxation rates on intensity must be analyzed. As discussed in Chapter 1, in addition to the 
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requirement of giving rise to a pair of isolated peaks, residues must also be chosen that do not 
have significantly different relaxation parameters between their cis and trans conformations. 
To ensure that differential relaxation effects would not affect the analysis, 1 H 
longitudinal relaxation times were measured for Itk SH2 using inversion recovery 
experiments. Table 2-1 reports the measured relaxation parameters for the residues used in 
the subsequent analysis. The table also illustrates that differences in the relaxation times 
between cis and trans states of the residues used in the analysis will not cause significant 
error in the measured cis/trans ratio in these experiments. Even the largest errors are well 
within experimental error, and considerably smaller than the relative differences in affinity 
· between cis and trans forms for the SH2 ligands. 
In order to fit (3) to the NMR data for Itk SH2 and its ligands, five residues were 
selected which fit the requisite criteria of peak isolation and relaxation uniformity. The 
volumes of the conformation-doubled HSQC peaks of these residues were then integrated 
over the course of a ligand titration. The trans to cis interconversion constant K' of free SH2 
is given directly by the integrated volume ratio of the cis and trans cross peaks (Table 2-2). 
Kc and Kt were then obtained by fitting (3) to the peak integral data of five cis/trans pairs 
(Figure 2-6). The solid lines in Figure 2-6 represent the fit of (3) to the NMR data. The 
values of Kc and Kt, as determined by the fit, are given in Table 2-2, along with the observed 
association constants for both ligand titrations. 
35 
Table 2-1. 1 H T 1 relaxation parameters for Itk SH2 residues used in the analysis of cis/trans 
population ratio. The magnetization recovered between scans (I/Io) is dependent on the 1H 
T 1 relaxation of the backbone amide as well as the relaxation delay used in the experiment. 
For all experiments in this chapter, a relaxation delay of 2 seconds was used. The largest 
error due to differential relaxation is expected for Lys 290, where I/Io differs by 5.9% 
between the cis and trans forms. All measurements were conducted on 1 mM SH2 at 298K. 
1H T 1 (ms) I/l0=exp(-T1/RD) 
Residue Cis trans CIS trans 
256 896±40 866±40 0.638 0.649 
257 1155±40 1160±40 0.561 0.560 
258 936±40 924±70 0.626 0.630 
260 1024±70 981±30 0.599 0.612 
278 1046±70 1052±70 0.593 0.591 
288 806±40 828±30 0.668 0.661 
290 998±30 876±40 0.607 0.645 
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Figure 2-5. Plot of the fraction of Itk SH2 in the cis conformation (fc) versus the total 
fraction of SH2 bound to ligand (Ji,) for (a) titration of phosphopeptide into a sample 
containing 15N-labeled Itk SH2 domain (0.32 mM), and (b) titration of the Itk SH3 domain 
into a sample containing 15N-labeled Itk SH2 domain (0.32 mM). Residues T256, K258, 
0257, F278, and 0260 were used in (a), while residues C288, K258, 0257, K290, and 0260 
were used in (b). Error bars represent two standard deviations about the mean. The solid 
line represents the best fit of (3) to the data. The dotted line represents the expected fraction 
of cis if phosphopeptide exclusively bound the trans conformer (Kc= 0) in (a) or Itk SH3 
exclusively bound the cis conformer (K1 = 0) in (b). 
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Table 2-2. Observed, cis, and trans association constants for Itk SH2 binding to each of its 
ligands. The error represents the standard deviation between the five residues used to 
measure the association constant. The actual uncertainty in the measurement is larger, 
including contributions from any systematic sources of error. In addition, the uncertainty in 
the measurement of K1 and Kc is affected by the uncertainty of the Ko measurement, which is 
used to calculate K1 and Kc The value for K' as measured in this method is 0.63 ± 0.07. The 
value for K'L (phosphopeptide) is 0.19 ± 0.02, while the value for K'L (SH3) is 2.2 ± 0.2. 
Itk SH2 binding phosphopeptide" 
(mM-1) 
21 ± 1 
29 ± 0.4 
8.4 ± 0.7 
Itk SH2 binding Itk SH3 
(mM-1) 
1.5 ± 0.1 
0.7 ± 0.1 
2.6 ± 0.1 
" Constants reported here for the SH2-phosphotyrosine binding differ from published 
values 13 due to different methods used to quantitate the peptide concentration. The published 
values used gravimetric methods to determine the peptide concentration, whereas the values 
reported here relied on amino acid analysis, as described in the materials and methods 
sections. Due to the inaccuracy of measuring small volumes, amino acid analysis was judged 
to give a more accurate measure of phosphopeptide concentration. It is worth noting, 
however, that both these values and the published values yield approximately the same ratio 
between cis and trans affinities (3.5 and 4, respectively). 
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Conclusions 
The method developed in this chapter shows that a quantitative analysis of the NMR 
data reveals the extent to which ligand-binding affinities are modulated by the isomerization 
between Itk conformations. While it was revealed that conformational exchange does not 
exclude binding of each ligand to its unpreferred conformer, each conformer exhibited a 3.5-
fold higher affinity for its respective ligand than the alternate conformation. Thus, for the Itk 
SH2 domain, cis/trans isomerization of a single prolyl imide bond affords this small domain 
the ability to control the relative binding affinities for distinct ligands during cell signaling. 
Despite great progress in the field over the last half-century, a great deal remains 
unknown regarding the structural mechanisms by which proteins recognize and modulate 
binding to their cellular targets. These precise structural questions are unaddressed by most 
biochemical experiments. Nevertheless, the importance of protein-protein interaction 
domains in modulating protein activity has emerged, particularly in cell signaling pathways. 
The mechanisms by which these domains alter their ligand-binding affinities may act to 
regulate the enzyme directly or affect the protein through binding of cellular targets. 
Proline isomerization, which is particularly difficult to detect by methods other than 
NMR, is a possibly widespread mechanism by which the modulation of ligand affinity may 
occur. The quantitative understanding of the effect of proline isomerization on ligand 
specificity may therefore prove to be an important matter in understanding the mechanisms 
by which the diversity and regulation of protein-protein interactions is achieved. 
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CHAPTER 3: FUTURE DIRECTIONS AND CONCLUSION 
Future Directions 
The method presented in Chapter 2 provides what is essentially a complete 
description of the extent to which the conformational heterogeneity of the Itk SH2 domain 
affects binding affinity to Itk SH3 and phosphopeptide. The logical extension of the ideas 
expressed in that chapter would be the application of the method to the study of more 
complex and biologically relevant systems. The obvious next step is examination of the 
effect of SH2 isomerization upon the dimerization of the SH3-SH2 fragment. Initial work, 
however, shows that the SH3SH2 fragment must be understood to a greater extent before 
such a detailed analysis can take place. Recent efforts have thus concentrated on 
characterizing the dimerization of this SH3SH2 dual domain in terms of the affinity of the 
association and the determination of its topology, before moving on to answer the question of 
the role of the proline switch in dimerization. 
Measuring Affinity 
The difficulty in applying the methods presented in chapter 1 to SH3SH2 lie in the 
fact that one cannot measure the affinity of the dimerization reaction in the same way as the 
single-domain interactions. Self-association affinity is typically measured by varying the 
concentration of the self-associating species. Because NMR requires high concentrations in 
order to achieve a good signal-to-noise ratio, the range of concentrations for which one can 
acquire clear spectra is quite limited. Therefore, attention has turned to measuring the 
association constant via other techniques. An approximate Ka(dimerJ (association constant for 
dimerization) of 40 mM- 1 has been reported earlier using analytical ultracentrifugation 1• 
Currently, the most attractive technique for deriving a reliable and quantitative measurement 
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of K01 dimer! for SH3SH2 seems to be the use of dynamic light scattering to monitor the 
dependence of the observed molecular weight on concentration. Initial efforts to conduct this 
study resulted in very noisy data, a result possibly due to interference from dust in the 
sample. This study is scheduled to be repeated taking additional measures to filter dust from 
the sample. 
An alternative approach that still allows the use of NMR is to fix the SH3SH2 
concentration and obtain the dimerization affinity by titrating in a peptide ligand that will 
bind one of the domains in such a way that the dimer is dissociated. By calibrating the 
affinity of the peptide for the single domain, the ability of the peptide to dissociate the dimer 
can be used to gauge the inherent affinity of the monomers for each other. 
There is, however, a difficulty associated with this approach as well. In fitting 
association curves to the SH2 domain using 11b/11omax• the chemical shift of free SH2 domain 
was known, and therefore K0 and Dbound were the only two unknowns. In the case of 
dimerization, neither Dbounct nor Dfree is known, and in initial efforts to extract K0 from such a 
competitive-peptide titration, this factor has proven significant in diminishing the reliability 
of the fit. 
Determining topology 
Another important question regarding the self-association of the SH3SH2 dual 
domain is the topology of the dimerized structure. Without knowing the structure of the 
entire SH3SH2 fragment, it is difficult to predict whether a symmetric, fully-occupied dimer 
is likely to form or if such a dimer is sterically unfeasible and the mode of self-association is 
an asymmetric, half-occupied dimer. A schematic of the two modes is presented in Figure 3-
1. The nature of the dimer topology will impact any mathematical model which attempts to 
assess of the impact of the proline switch in the SH2 domain on dimerization. 
a 
2 SH3 SH2 
b 
2 SH3 SH2 
.... ____ .. 
SH3 
.... ____ .. 
SH3 
SH2 
SH3 SH2 
Figure 3-1. Possible topological states of the SH3SH2 dimer. (a) A symmetric, fully-
occupied dimer. (b) An asymmetric, half-occupied dimer. 
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This question is being probed using compensatory mutants. ltk SH3SH2 (W208K) is 
a mutant developed by the laboratory of Leslie Berg that abrogates all intermolecular 
interactions with the SH3 domain binding groove. NMR studies reveal that the attached SH2 
domain is unaffected and that the construct behaves in an entirely monomeric fashion. Our 
lab is attempting to develop a similar mutation in the SH2 domain that eliminates binding of 
SH3. Mutants developed thus far precipitate at high concentrations, and this question has 
thus proven difficult to answer using NMR. In addition to developing and screening new 
mutants, efforts are also underway to measure the ability of the compensatory mutants to 
bind each other either using other techniques. 
While the behavior of the ltk SH3 and SH2 domains is well understood in 
experiments involving the isolated domains, the larger SH3SH2 construct remains 
insufficiently characterized. A better understanding of this fragment and its self-associating 
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behavior would give much-needed insight into the nature of Itk dimerization, the functional 
significance of which in the full-length protein remains very unclear. 
Conclusion 
As a conclusion to this thesis, I feel it is important to address the question of what the 
significance of this work is beyond what was previously understood. To answer that 
question, I would present the following main points regarding the significance of the 
completed work presented here. 
• Cis/trans isomerization does not confer full-ligand binding specificity to the Itk SH2 
domain. Figure 2-6 convincingly shows that while cis/trans isomerization certainly 
imparts specificity to its associated conformers, ltk SH2 in the cis conformation is 
still capable of binding phosphopeptide, and Itk SH2 in the trans conformation is 
capable of binding ltk SH3. Therefore, either more interactions are required to confer 
additional specificity, or the unpreferred interactions are physiologically relevant. 
Either way, mechanistic models of the activation of Itk must take this finding into 
account. 
• In addition to the Itk specific findings, these results are of general interest in gaining a 
greater quantitative understanding of the magnitude of effects that proline switches 
may be capable of. 
• The development of this methodology for independently measuring the independent 
ligand-binding association constants for multiple distinct protein conformations in a 
solution could be of general use in studying other such systems. While in theory this 
method is applicable to any conformationally heterogeneous protein, it is unclear 
whether conformational exchange events exist other than proline isomerization that 
would occur slowly enough to give rise to slow exchange NMR peaks, and yet fast 
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enough that physical separation of the two conformations is not feasible. Essentially 
then, the significance of this method is tied to the significance of praline switches. If 
in fact, praline switches are a widespread form of molecular control, then the 
quantitative study and understanding of them will prove important, and this type of 
analysis may prove a useful tool in probing them. 
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APPENDIX: MATLAB SCRIPTS 
Four MATLAB scripts are included in this appendix: 
• fitproteinligandcurve.m (fits an association constant to a protein-ligand titration). 
• fitproteinliganderror.m (called by fitproteinligandcurve; generates a sum of squares 
error for comparing observed data to theoretical prediction). 
• fitmlciscurve.m (fits association constants for cis and trans conformers to the cis-trans 
ligand-binding model). 
• fitmlciserror.m (called by fitmlciscurve; generates a sum of squares error for 
comparing observed data to theoretical prediction). 
%This function fits an association constant to a protein-ligand titration 
%and plots a binding curve depicting the association. 
%Cone = Array containing the concentration of protein and ligand as they 
%vary throughout the titration. 
%DeltaArr = Array containing the imported chemical shifts. 
%Start;End = Peaks to which the data should be fit (i.e. columns in 
%DeltaArr that should be used by the program). 
%KaEst Rough estimate of the Ka of the interaction, in rnMA(-1) 
%KaArr Array containing association constants as determined by each peak 
%used in the fit. 
%KaAve = Average of the association constants contained in KaArr. 
%KaErr = Standard deviation of the association constants containted in 
%KaArr. 
%DataPoints = Array containing the Y axis values for the data points 
%plotted in the binding curve. 
function [KaArr, KaAve, KaErr, DataPoints, DeltaBound] 
fitproteinligandcurve(Conc, DeltaArr, Start, End) 
%PART I: PROCESSING THE RECEIVED VARIABLES 
ProteinConc = Conc(:,2); 
LigandConc = Conc(:,l); 
Points= size(ProteinConc); 
Points= Points(l); 
%Points Number of points in the titration 
Options optimset( 'Display', 'iter' ); 
%Required by fminsearch to display optimization output 
Value = 1; 
%Needed to ensure KaArr, KbArr start at 1 even if Start is not equal to 1 
%Difference 
%DeltaBound 
DeltaArr(Points,:) - DeltaArr(l,:); 
DeltaArr(l,:) +Difference; 
%PART II: OPTIMIZING THE FIT 
for i = Start:End 
StartParams(l) 
StartParams(2) 
%StartParams = 
1; 
DeltaArr(Points, i); 
Initial values for Ka, DeltaBound that will be 
optimized 
%by fminsearch 
Params = fminsearch('fitproteinliganderror', StartParams, Options, 
Conc(2:Points, :), DeltaArr(2:Points, i), DeltaArr(l,i)); 
KaArr(Value) = Params(l); 
DeltaBound(Value) = Params(2); 
%Params, KaArr, DeltaBound = Optimized values yielded by fminsearch 
for j = 2:Points 
DataPoints(j, Value) = (abs(DeltaArr(j,i) -
DeltaArr(l,i)))/(abs(DeltaBound(Value) - DeltaArr(l,i))); 
end 
Value Value + 1; 
end 
KaAve 
KaErr 
mean(KaArr); 
std(KaArr); 
%PART III: PLOTTING THE DATA POINTS 
hold off; 
axis([O 4.5 0 1.05]); 
hold on; 
%Creates a figure window and determines the x and y axes of the plot 
for i =!:(Points - 1) 
end 
DataPointsMean(i) = mean(DataPoints(i + 1,:)); 
Error(i) = 2*std(DataPoints(i + 1,:)); 
%Optional: This section can be decommented and the preceding section 
%commented in order to toggle between displaying the binding curve as a 
%scatter plot or with error bars. 
%for i = l:(Value - 1) 
% plot(Conc(2:Points,1), FittedCurveArr(2:Points,i), 'ko' ); 
% hold on; 
%end 
errorbar(Conc(2:Points,1), DataPointsMean, Error, 'ko' ); 
hold on; 
%Plots the data points as black circles 
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%PART IV: PLOTTING THE BINDING CURVE 
ProteinConcMin min(Conc(:,2)); 
ProteinConcMax = max(Conc(:,2)); 
LigandConcMax = max(Conc(:, 1)); 
LigandConc = 0.0001:0.0l:LigandConcMax; 
Points= size(LigandConc); 
Points= Points(2); 
%Points = Number of points for which the value of the value of the binding 
%curve is calculated 
for i = !:Points 
ProteinConc(i) = ProteinConcMax - (ProteinConcMax -
ProteinConcMin)*i/Points; 
end 
%Protein concentration is assumed to vary linearly with ligand 
%concentration over the course of the titration 
for i = !:Points 
a2 KaAve; 
end 
al -KaAve*ProteinConc(i) - KaAve*LigandConc(i) - 1; 
aO KaAve*ProteinConc(i)*LigandConc(i); 
FittedConcPL(i) = (-al - sqrt(al*al - 4*a2*a0))/(2*a2); 
FittedConcL(i) = LigandConc(i) - FittedConcPL(i); 
FittedConcP(i) = ProteinConc(i) - FittedConcPL(i); 
%Concentrations of protein-ligand complex, free ligand, and free 
%protein, respectively 
FittedCurve(i) = FittedConcPL(i)/ProteinConc(i); 
plot(LigandConc, FittedCurve,'k'); 
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%This function returns a value corresponding to the sos error of fitting a 
%simple protein-ligand binding model to the data given using the passed 
%values for bound chemical shift and association constant. 
%Params = Parameters being minimized by fminsearch (Kd and DeltaBound) 
%Cone = Array containing the concentration of protein and ligand as they 
%vary throughout the titration (unlike other programs, Cone here does not 
%include the first point of the titration). 
%DeltaArr = Array containing the imported chemical shifts (again, does not 
%include here the first titration point). 
%DeltaFree =Rough estimate of the Ka of the interaction, in mMA(-1) 
%Error = Sum of the squares of the difference between the value of the 
%fitted curve at a titration point and the experimentally observed value. 
%2003 Patrick Breheny. 
function Error = fitproteinliganderror(Params,Conc,DeltaArr,DeltaFree) 
KaEst = Params(l); 
DeltaBoundEst = Params(2); 
%DeltaBoundEst = DeltaBound; 
%KaEst = Estimated value of the association constant. 
%DeltaBoundEst = Estimated value of the chemical shift for the protein 
%bound to ligand. 
ProteinConc = Conc(:,2); 
LigandConc = Conc(:,l); 
Points= size(ProteinConc); 
Points= Points(l); 
%Points = Number of titration points (not including the first, which has 
no 
%ligand added). 
for i = l:Points 
a2 KaEst; 
al -KaEst*ProteinConc(i) - KaEst*LigandConc(i) - l; 
aO KaEst*ProteinConc(i)*LigandConc(i); 
FittedConcPL(i) =(-al - sqrt(al*al - 4*a2*a0))/(2*a2); 
FittedConcL(i) = LigandConc(i) - FittedConcPL(i); 
FittedConcP(i) = ProteinConc(i) - FittedConcPL(i); 
%Concentrations of protein-ligand complex, free ligand, and free 
%protein, respectively 
FittedCurve(i) = DeltaFree*FittedConcP(i)/ProteinConc(i) + 
DeltaBoundEst*FittedConcPL(i)/ProteinConc(i); 
end 
for i = l:Points 
ErrorVector(i) 
end 
FittedCurve(i) - DeltaArr(i); 
Error= sum(ErrorVector.A2); 
%This function fits association constants for the cis and trans forms of a 
%confomationally heterogenous protein to a FractionCis/FractionBound curve 
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%based on an observed Ka and compares it to a model in which only the cis 
%conformation binds. 
%Cone = Array containing the concentration of protein and ligand as they 
%vary throughout the titration. 
%CVol, TVol = Array containing the integrated volumes of cis and trans 
%peaks, respectively, as they vary throughout the titration. 
%Start;End = Peaks to which the data should be fit (i.e. columns in 
%CVol, TVol that should be used by the program). 
%Ko = Observed Ka of the interaction, ignoring isomerization. 
%KPrime = Interconversion constant between the two isomers. 
%KCisArr, KTransArr = Array containing association constants as determined 
%by each peak used in the fit. 
%KCisAve, KTransAve = Average of the association constants contained in 
%KCiSArr, KTransArr. 
%KCisErr, KTransErr = Standard deviation of the association constants 
%contained in KCisArr, KTransArr. 
%DataPoints = Array containing the Y-axis values for the data points 
%plotted in the binding curve. 
function [KCisArr, KTransArr, KCisAve, KTransAve, KCisErr, KTransErr, 
DataPoints] = fitmlciscurve(Conc, CVol, TVol, Start, End, Ko, KPrime) 
%PART I: Processing the received variables 
ProteinConc = Conc(:,2); 
LigandConc = Conc(:,l); 
Points = size(ProteinConc); 
Points= Points(l); 
%Points = Number of points in the titration 
for i = 2:Points 
FractionBound(i - 1) = (ProteinConc(i) + LigandConc(i) + (l/Ko) -
sqrt(((ProteinConc(i) + LigandConc(i) + (l/Ko))~2) -
4*ProteinConc(i)*LigandConc(i)))/(2*ProteinConc(i)); 
end 
Fractioncis = CVol(2:Points,:)./(TVol(2:Points,:) + CVol(2:Points,:)); 
%FractionBound = Fraction of total protein bound to ligand. This is 
%calculated at each point in the titration based on the observed Ka of the 
%association. 
%FractionCis = Fraction of total protein in cis conformation. 
Options= optimset( 'Display', 'iter' ); 
Value = l; %Needed to ensure KaArr, KbArr start at 1 even if 
Start is not equal to 1 
%PART II: Optimizing the fit 
for i = Start:End 
StartParam = Ko; 
%StartParam = Initial value for KCis that will be optimized by 
%fminsearch 
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Parrun = fminsearch('fitmlciserror', StartParam, Options, 
FractionBound, FractionCis(:,i), KPrime, Ko); 
KCisArr(Value) = Param; 
end 
KTransArr(Value) = Ko*(l + KPrime) - KCisArr(Value)*KPrime; 
%Param, KCisArr, KTransArr = Optimized values yielded by fminsearch. 
%Values for KCis and KTrans are independent of which parameter is 
%directly fit by fminsearch. 
Value = Value + l; 
KCisAve mean(KCisArr); 
KTransAve = mean(KTransArr); 
KCisErr = std(KCisArr); 
KTransErr = std(KTransArr); 
KPrimeLigandArr KPrime*KCisArr./KTransArr; 
KP~imeLigandAve mean(KPrimeLigandArr); 
KPrimeLigandErr std(KPrimeLigandArr); 
%KPrimeLigand variables = Values for K'L. By default, these values are 
not 
%set to print. However, removing the semicolon after the above lines will 
%display the KPrimeLigand variables. 
%PART III: Plotting the data points 
hold off; 
axis([O 1 0 l]); 
hold on; 
DataPoints = FractionCis(:,Start:End); 
for i = l:(Points - l) 
FractionCisMean(i) = mean(FractionCis(i,Start:End)); 
Error(i) = 2*std(FractionCis(i,Start:End)); 
end 
errorbar(FractionBound, FractionCisMean, Error, 'ko' ); 
%Optional: This section can be decommented and the preceding section 
%commented in order to toggle between displaying the binding curve as a 
%scatter plot or with error bars. 
%for i = l:(Value - 1) 
% plot(FractionBound, FractionCis(:,i), 'ko' ); 
% hold on; · 
%end 
%PART IV: Plotting the binding curve 
Fb = 0.0001:0.01:1; 
%Fb = FractionBound for the fitted binding curve 
Points 
Points 
size(Fb); 
Points(2); 
for i = l:Points 
Fc(i) = ((KPrime*(KCisAve - KTransAve))/((l + KPrime)*(KTransAve + 
KCisAve*KPrime)))*Fb(i) + KPrime/(1 + KPrime); 
52 
end 
%Fe = FractionCis for the fitted binding curve 
KTransModel = O; 
KCisModel = Ko*(l + KPrime)/KPrime; 
%Optional: This section can be decommented and the preceding section 
%commented in order to toggle between displaying a model curve displaying 
%all-trans binding or all-cis binding. 
%KTransModel = Ko*(l + KPrime); 
%KCisModel = 0; 
for i = l:Points 
FcModel(i) = ((KPrime*(KCisModel - KTransModel))/((l + 
KPrime)*(KTransModel + KCisModel*KPrime)))*Fb(i) + KPrime/(l + KPrime); 
end 
%FcModel = FractionCis for the model in which the ligand binding is 
%absolutely conformationally dependent. 
plot ( Fb, Fe, 'k' ) ; 
hold on; 
plot(Fb, FcModel, '--k'); 
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%This function returns a value corresponding to the SOS error of fitting a 
%binding model to the data given using the passed value for an association 
%constant in the system. This program is based on a model in which a 
%conformationally heterogenous protein binds is capable of binding to a 
%non-conformationally heterogenous protein in the absence of 
%self-association. The passed parameter in this case is the association 
%constant of one of the conformers. 
%Param = Parameter being minimized by fminsearch (KCis) 
%FractionBound = Array containing the total fraction of protein bound to 
%ligand as it varies throughout the titration. (does not include the first 
%point of the titration). 
%FractionCis = Array containing the total fraction of protein in the cis 
%conformation at it varies throughout the titration (again, does not 
%include the first titration point). 
%KPrime, Ko = Conformer exchange equilibrium constant and protein-ligand 
%association constant, respectively (determined separately). 
%Error = Sum of the squares of the difference between the value of the 
%fitted curve at a titration point and the experimentally observed value. 
%2003 Patrick Breheny 
function Error = fitmlciserror(Param, FractionBound, FractionCis, KPrime, 
Ko) 
Kc Est 
KtEst 
Points 
Points 
Par am; 
Ko*(l + KPrime) - KcEst*KPrime; 
size(FractionBound); 
Points(2); 
for i = !:Points 
FractionCisPredicted(i) = ((KPrime*(KcEst - KtEst))/((l + 
KPrime)*(KtEst + KcEst*KPrime)))*FractionBound(i) + KPrime/(l + KPrime); 
end 
%Generation of fitted curve based on parameters. 
for i = !:Points 
Errorvector(i) = FractionCisPredicted(i) - FractionCis(i); 
end 
%Generation of error vector based on difference between fitted curve and 
%real data 
Error= sum(ErrorVector.A2); 
%Minimization is run on the sum of the squares at each point 
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